Fil LTD Regeneron Pharmaceuticals, Inc. Transaction History

Fil LTD

$103 Billion
Q3 2024

A detailed history of Fil LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fil LTD holds 100,809 shares of REGN stock, worth $74.6 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

100,809

Previous 94,499 6.68%

Holding current value

$74.6 Million

Previous $99.3 Million 6.7%

% of portfolio

0.1%

Previous 0.1%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $6.46 Million - $7.58 Million	6,310 Added 6.68%	100,809 $106 Million
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $4.63 Million - $5.61 Million	5,240 Added 5.87%	94,499 $99.3 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $8.68 Million - $9.55 Million	9,613 Added 12.07%	89,259 $85.9 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $14.5 Million - $16.4 Million	18,654 Added 30.58%	79,646 $70 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $15.3 Million - $18.7 Million	22,157 Added 57.05%	60,992 $50.2 Million
Q2 2023 Aug 11, 2023	BUY	$700.03 - $830.35 $23.9 Million - $28.3 Million	34,118 Added 723.3%	38,835 $27.9 Million
Q1 2023 May 11, 2023	SELL	$680.49 - $826.97 $400,128 - $486,258	-588 Reduced 11.08%	4,717 $3.88 Million
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $3.74 Million - $4.06 Million	5,303 Added 265150.0%	5,305 $3.83 Million
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $1,147 - $1,448	2 New	2 $1,000
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $219,340 - $295,536	-400 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $88.1 Million - $103 Million	-147,994 Reduced 99.73%	400 $279,000
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $143 Million - $177 Million	-263,668 Reduced 63.99%	148,394 $93.7 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $32.8 Million - $38.9 Million	-57,124 Reduced 12.18%	412,062 $249 Million
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $39.3 Million - $46.4 Million	83,083 Added 21.52%	469,186 $262 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $55.6 Million - $68.3 Million	124,556 Added 47.62%	386,103 $183 Million
Q4 2020 Feb 08, 2021	SELL	$478.3 - $607.98 $10.9 Million - $13.9 Million	-22,812 Reduced 8.02%	261,547 $126 Million
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $151 Million - $183 Million	-278,104 Reduced 49.44%	284,359 $159 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $42.2 Million - $55 Million	85,490 Added 17.92%	562,463 $351 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $160 Million - $236 Million	476,952 Added 2271200.0%	476,973 $233 Million
Q4 2019 Feb 07, 2020	BUY	$274.13 - $376.51 $274 - $376	1 Added 5.0%	21 $8,000
Q1 2019 May 13, 2019	BUY	$372.08 - $439.57 $7,441 - $8,791	20 New	20 $8,000
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $3.56 Million - $4.43 Million	-11,257 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$431.38 - $504.0 $6.76 Million - $7.9 Million	-15,681 Reduced 58.21%	11,257 $5.03 Million
Q2 2017 Aug 29, 2017	BUY	N/A	26,938	26,938 $13.2 Million

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account